Moleculin Biotech received FDA guidance reducing its Phase 3 trial size for Annamycin in AML. First unblinding is expected in ...

China's agriculture ministry issued guidelines on Friday to promote biotech cultivation from 2024 to 2028, a ministry ...

Biotech and drug stocks, collectively, are down an average of 16% over the past three months. The closely watched XBI index ...

Under the terms of this agreement, Beihai Biotech will be responsible for the manufacturing and supply of the product. Zydus ...

“If small biotech companies like ours are forced to scale back or shut down, it will not just be a loss for scientific ...

Financial writer advises caution on Jyong Biotech Ltd. IPO due to high debt, legal issues, and FDA challenges. Click for my ...

A federal judge will soon decide whether to dismiss a lawsuit against UnitedHealth Group alleging that the company and its ...

The Senate has voted to confirm Robert F. Kennedy Jr. as the next secretary of health and human services, with Sen. Mitch ...

The aggregate gross proceeds to the Company from the offering are expected to be approximately $1.05 million, before ...

By fusing circular dichroism with high-resolution microspectroscopy and microscopic imaging, this cutting-edge technology is ...

Oxford Cannabinoid Technologies is shedding its old skin. Having delisted its stock last year, the biotech is rebranding as ...

Jim Tressel possesses something a lot of politicians lack, as cleveland.com’s Terry Pluto, who’s known Tressel a long time, ...